Commercialization Project Development Teams

Consult with experienced researchers and industry experts to bring your idea to market. The Indiana CTSI has two PDTs geared toward commercialization: the MedTech Commercialization PDT, which focuses on devices, and the Drug Commercialization PDT, which focuses on pharmaceutical treatments.

Partner with the Commercialization PDTs

Find the Right Fit

The MedTech Commercialization PDT supports academic and clinical investigators who are working to advance their innovative medical devices and software ideas through early phase development toward commercialization and clinical use.

Team Members

The Drug Development to Commercialization Program (PDT) is a comprehensive initiative designed to empower academic and clinical investigators to navigate the intricate process of transforming groundbreaking discoveries into market-ready therapeutics and diagnostics.

Our program provides expert guidance, resources, and support at every stage of the journey—from early-stage discovery and preclinical development to clinical trials, regulatory approval, and commercialization.

Team Members

How It Works

Benefits to working with the Commercialization PDTs

The Commercialization PDTs Provide:

Education and Mentorship Areas

Did You Know?

Indiana CTSI Institutions have offices dedicated to commercialization. The Commercialization PDTs have representatives from these offices at Indiana University, Purdue University, and the University of Notre Dame.

Frequently Asked Questions

Any independent investigator in the state of Indiana is eligible to apply and receive advice. This includes full-time faculty (i.e., tenure-track, research, and clinical faculty) as well as entrepreneurs in Indiana working on health-based products. Graduate students, research scientists, and postdocs are eligible for advice with the support of a faculty mentor.

Full-time faculty (i.e., tenure-track, research, and clinical faculty) at any campus of Indiana University, the University of Notre Dame, or Purdue University who have submitted all relevant invention disclosures to their university’s commercialization office are eligible for funding.

Projects should focus on developing a product that has the potential to improve human health (e.g., therapeutic, diagnostic, medical device). Advice and funding from this group will focus on steps necessary to bring this product to market (commercialization) rather than basic science research.
The program does not restrict the stage of product development; we provide mentorship for projects from the early stages to the advanced stages, such as those at the investigational new drug (IND) and investigational device exemption (IDE) stage.

There are no requirements for cost-sharing or matching funds.

The process begins by filling out a brief application form. A member of the commercialization PDT will follow-up with you to schedule an initial meeting to learn more about your project. If the project is deemed to be a good fit, we will ask you to submit a more detailed application and schedule your project for presentation at a PDT meeting.

There are no restrictions on how often the investigator can receive mentorship from the team.

If awarded funding, the program requires periodic progress reports on progress towards milestones, as well as any commercialization outcomes.

The program provides advice for Indiana startups that are not already affiliated with the Indiana CTSI partnering institutions on a space-available basis.

The Indiana CTSI does not retain any rights to IP developed through funded projects.

Contact

  • Kara Garcia, PhD, MEng
    MedTech Program Manager
    Email

  • Padma Portonovo, PhD, MBA
    Drug Development Program Manager
    Email

  • Scott Denne, MD
    Director